TMPRSS11D and Parkinson disease: Therefore, to restore the balance of histone acetylation levels and reduce cell damage in PD, HAT inhibitors or selective inhibitors targeting HDAC2, HDAC3, or HDAC4 are preferable to nonspecific HDAC inhibitors.323